Shanghai RAAS Blood Products Balance Sheet Health
Financial Health criteria checks 6/6
Shanghai RAAS Blood Products has a total shareholder equity of CN¥30.5B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥32.8B and CN¥2.3B respectively. Shanghai RAAS Blood Products's EBIT is CN¥2.2B making its interest coverage ratio -7.7. It has cash and short-term investments of CN¥4.9B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
Interest coverage ratio | -7.7x |
Cash | CN¥4.93b |
Equity | CN¥30.46b |
Total liabilities | CN¥2.32b |
Total assets | CN¥32.78b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002252's short term assets (CN¥9.3B) exceed its short term liabilities (CN¥2.3B).
Long Term Liabilities: 002252's short term assets (CN¥9.3B) exceed its long term liabilities (CN¥33.0M).
Debt to Equity History and Analysis
Debt Level: 002252 is debt free.
Reducing Debt: 002252 had no debt 5 years ago.
Debt Coverage: 002252 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 002252 has no debt, therefore coverage of interest payments is not a concern.